The Evidence Based Rheumatology Podcast

28 Oct 2024 06:31

E115: Benralizumab for EGPA - the MANDARA Study

Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.

MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155

Отзывы

Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.

Social networks

Select language

🇺🇸